|
|
Line 7: |
Line 7: |
| <tr align="left"> | | <tr align="left"> |
| <td> | | <td> |
- | <p> | + | |
- | Optogenetics, a novel technology that allows temporal and spatial induction of gene expression by the
| + | |
- | use of light, is of growing importance for fundamental research and clinical applications. However, its
| + | |
- | biggest limitation is the time consuming introduction of transgenes into organisms or cell lines. In
| + | |
- | contrast, easy but unspecific gene delivery can be achieved by viral vectors. We, the iGEM Team
| + | |
- | Freiburg 2014, combine the advantages of both approaches – the temporal and spatial resolution of
| + | |
- | optogenetics, and the simplicity of gene transfer offered by viruses. To this end we designed a system
| + | |
- | where the entry of a virus is enabled or prevented by exposing the target cells to light of distinct
| + | |
- | wavelengths.
| + | |
- | <br />
| + | |
- | <br />
| + | |
- | The ecotropic murine leukemia virus (MuLV) is a retroviral vector which enters a cell by binding to the
| + | |
- | cationic amino acid transporter (CAT-1). CAT-1 is present in cells of all mammals, but displays a high
| + | |
- | variability between different species in the third extracellular loop, which is the recognition sequence
| + | |
- | for the virus. Therefore, even close relatives of mice, e.g. rats or hamsters, are immune to the MuLV,
| + | |
- | but upon exogenous expression of murine CAT-1, cell lines from these species can also be infected.
| + | |
- | Hence we use the popular Chinese hamster ovary cell line CHO in our experiments.
| + | |
- | <br />
| + | |
- | <br />
| + | |
- | For optogenetic targeting of specific subsets of cells, we employ three different systems: a red/far-red
| + | |
- | light system and a UVB light system based on proteins from the plant model organism Arabidopsis
| + | |
- | thaliana as well as a light-oxygen-voltage system from the marine bacterium Erythrobacter litoralis. In
| + | |
- | all three light systems gene expression is induced by recruitment of engineered transcription factors to
| + | |
- | DNA.
| + | |
- | <br />
| + | |
- | <br />
| + | |
- | Without illumination the cells are in a dormant state and cannot be infected by the viral vector. Upon
| + | |
- | exposure to the appropriate wavelength, they start expressing the viral entry receptor CAT-1. Addition
| + | |
- | of the viral vector to the culture medium leads to infection of the activated subset of cells.
| + | |
- | In order to demonstrate the functionality of the specific gene delivery we developed a device for
| + | |
- | secure communication. The device is working in a two-step process: First, the sender has to specify
| + | |
- | the subset of cells by illumination through a patterned mask. In the second step, upon receiving the
| + | |
- | device the reader has to visualize the message by adding the appropriate viral vector containing a
| + | |
- | reporter gene. The unintended opening of the device by an unaware third person results in a complete
| + | |
- | illumination of the cells leading to the destruction of the message. The time gap between sending and
| + | |
- | receiving the device is limited by the half-life of the receptor, thus creating an additional safety level.
| + | |
- | To expand into the field of medicine, we furthermore chose CRISPR/Cas as a gene cargo.
| + | |
- | <br />
| + | |
- | <br />
| + | |
- | CRISPR/Cas has attracted much attention in recent past, as it facilitates specific gene editing, e.g.
| + | |
- | knock-outs/ins, with high specifity in a minimum of time. In combination with delivery by viral vectors
| + | |
- | this could provide a powerful tool for the treatment of diseases and genetic disorders in vivo.
| + | |
- | </p></td>
| + | |
| </tr> | | </tr> |
| </table> | | </table> |